2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burry, KA; Hermsmeyer, RK; Katzenellenbogen, BS; Katzenellenbogen, JA; Mishra, RG; Nealen, ML; Oparil, S; Stanczyk, FZ | 1 |
| Barton, M; Bhattacharya, I; Haas, E; Li, H; Minotti, R; Stettler, CD; Traupe, T | 1 |
2 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Metabolite ligands of estrogen receptor-beta reduce primate coronary hyperreactivity.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Cutaneous; Androstane-3,17-diol; Animals; Calcium Signaling; Chrysenes; Coronary Vasospasm; Estriol; Estrogen Receptor beta; Female; Gene Expression; Genistein; Macaca mulatta; Muscle, Smooth, Vascular; Nitriles; Propionates; Receptors, Thromboxane; Serotonin; Vasoconstriction | 2006 |
Distinct roles of estrogen receptors alpha and beta mediating acute vasodilation of epicardial coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bradykinin; Cells, Cultured; Coronary Vessels; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Hormone Replacement Therapy; Humans; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitriles; Pericardium; Phenols; Pyrazoles; Superoxides; Swine; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2007 |